-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

TCR Engineering of Immune Cells to Enhance Responses to Blood Cancers

Program: Scientific Program
Session: Joint Session: Genome Engineering for Enhanced Blood Cancer Immunotherapy
Sunday, December 10, 2023, 9:30 AM-11:05 AM

Chiara Bonini, MD

IRCCS Ospedale San Raffaele, Milano, Italy; University Vita-Salute San Raffaele, Milan, Italy

Disclosures: Bonini: PAN CANCER: Membership on an entity's Board of Directors or advisory committees; CHROMA: Consultancy; GENYO: Membership on an entity's Board of Directors or advisory committees; ALIA THERAPEUTICS: Membership on an entity's Board of Directors or advisory committees; INTELLIA THERAPEUTICS: Membership on an entity's Board of Directors or advisory committees, Research Funding; SMART IMMUNE: Membership on an entity's Board of Directors or advisory committees.

See more of: Joint Session: Genome Engineering for Enhanced Blood Cancer Immunotherapy
See more of: Scientific Program
<< Previous Presentation | Next Presentation >>